App-Quantinova.ai

Calgranulin B/S100A9 and KL-6 in bronchoalveolar lavage of patients with IPF and NSIP.

David Bennett - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Idiopathic interstitial pneumonias

N/A

Functional assessment of newly identified SFTPA1 and SFTPA2 mutations in patients with idiopathic interstitial pneumonia (IIP) and lung cancer

Nadia Nathan - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Idiopathic interstitial pneumonias

N/A

Prevalence of pleuroparenchymal fibroelastosis (PPFE): A retrospective single-centre case study

Silvana Geleff - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Idiopathic interstitial pneumonias

N/A

SERUM SOLUBLE IL‐2 RECEPTOR IS A POSSIBLE PROGNOSTIC BIOMARKER IN IDIOPATHIC INTERSTITIAL PNEUMONIA

YOSHINORI TANINO - Asian Pacific Society of Respirology (APSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Idiopathic interstitial pneumonias

N/A

THE ROLE OF FOLLOW‐UP EVALUATION IN THE DIAGNOSTIC ALGORITHM OF IDIOPATHIC INTERSTITIAL PNEUMONIA: A RETROSPECTIVE STUDY

QIAN HAN - Asian Pacific Society of Respirology (APSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Idiopathic interstitial pneumonias

N/A

BIOMARKERS FOR CONNECTIVE TISSUE DISEASE-ASSOCIATED INTERSTITIAL LUNG DISEASE: A PILOT STUDY

Y. H. Chiu - European League Against Rheumatism (EULAR) , 2021

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Idiopathic interstitial pneumonias

N/A

DEVELOPMENT OF A DIAGNOSTIC ALGORITHM FOR THE DIFFERENTIAL DIAGNOSIS OF INTERSTITIAL LUNG DISEASE: PRELIMINARY DATA FROM A MULTICENTER RETROSPECTIVE CASE-CONTROL STUDY

B. Maranini - European League Against Rheumatism (EULAR) , 2021

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Idiopathic interstitial pneumonias

N/A

Imaging of Pneumonitis

M. Nishino - IASLC World Conference on Lung Cancer (IASLC WCLC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Idiopathic interstitial pneumonias

L-Tyrosine

Effect of Antifibrotic Therapies in Patients with Interstitial Pneumonia with Autoimmune Features

Alexandra Nagy - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Idiopathic interstitial pneumonias

Pirfenidone

Destructive bronchiolitis: a characteristic pathological feature of interstitial lung disease preceding the onset of rheumatoid arthritis

Midori Sato - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Idiopathic interstitial pneumonias

N/A

Distinctive polarization of circulating classical monocytes between idiopathic pulmonary fibrosis and idiopathic nonspecific interstitial pneumonia

Masahiro Yamashita - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Idiopathic interstitial pneumonias

N/A

Severity before or at the onset of acute exacerbation (AE can predict the long-term and short-term survival of AE in idiopathic interstitial pneumonias (IIPs?

Toru Arai - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Idiopathic interstitial pneumonias

N/A

Impact of BAL lymphocytosis > 15% on the prognosis of chronic idiopathic interstitial pneumonias other than idiopathic pulmonary fibrosis: a retrospective nationwide study based on multidisciplinary discussion

Akira Yamagata - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Idiopathic interstitial pneumonias

N/A

The study of telomere associated genes and telomere measurement in Idiopathic Pulmonary Fibrosis

Halime Yıldırım - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Idiopathic interstitial pneumonias

N/A

PULMONARY VENO-OCCLUSIVE DISEASE/PULMONARY CAPILLARY HEMANGIOMATOSIS: A LESSON LEARNED FROM AN UNSUCCESSFUL EXPERIENCE

Hiroki Nakayama - American College of Cardiology (ACC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Idiopathic interstitial pneumonias

N/A

Disease behaviour and prognostic factors in Hypersensitivity Pneumonitis with UIP-like pattern

Maria João Freitas Ferreira Araújo - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Idiopathic interstitial pneumonias

N/A

Validation of Clinical Criteria for Progressive Fibrosing Interstitial Lung Disease

J. V. Pugashetti - American Thoracic Society (ATS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Idiopathic interstitial pneumonias

N/A

Comparison of Interstitial Lung Disease Diagnoses in Urban and Rural Areas Among Patients in the Pulmonary Fibrosis Foundation Patient Registry

A. E. Dimmock - American Thoracic Society (ATS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Idiopathic interstitial pneumonias

aluminum hydroxide / magnesium hydroxide Chewable / simethicone

Giant Cell Interstitial Pneumonia: A Case Report

A. Malik - American Thoracic Society (ATS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Idiopathic interstitial pneumonias

Prednisone

Filters

59 Abstracts